A carregar...

An Elvitegravir Nanoformulation Crosses the Blood–Brain Barrier and Suppresses HIV-1 Replication in Microglia

Even with an efficient combination of antiretroviral therapy (ART), which significantly decreases viral load in human immunodeficiency virus type 1 (HIV-1)-positive individuals, the occurrence of HIV-1-associated neurocognitive disorders (HAND) still exists. Microglia have been shown to have a signi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Viruses
Main Authors: Gong, Yuqing, Zhi, Kaining, Nagesh, Prashanth K. B., Sinha, Namita, Chowdhury, Pallabita, Chen, Hao, Gorantla, Santhi, Yallapu, Murali M., Kumar, Santosh
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7290679/
https://ncbi.nlm.nih.gov/pubmed/32443728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v12050564
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!